These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 15757531)

  • 1. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
    Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
    Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
    Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
    Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
    Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
    Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
    Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
    Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
    Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
    Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
    Lou Y; Fang CQ; Li JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
    Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
    Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.
    Liu PY; Li YH; Chan SH; Lin LJ; Wu HL; Shi GY; Chen JH
    Am J Cardiol; 2006 Oct; 98(8):1012-7. PubMed ID: 17027562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
    Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
    Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
    Szyllo K; Smolarz B; Romanowicz-Makowska H; Niewiadomski M; Kozlowska E; Kulig A
    J Exp Clin Cancer Res; 2002 Sep; 21(3):357-61. PubMed ID: 12385578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.
    Smolarz B; Szyłło K; Romanowicz-Makowska H; Niewiadomski M; Kozłowska E; Kulig A
    Pol J Pathol; 2003; 54(4):233-8. PubMed ID: 14998290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
    Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.